Steris PLC (NYSE:STE) – Investment analysts at KeyCorp increased their FY2018 earnings per share (EPS) estimates for Steris in a research note issued on Thursday. KeyCorp analyst M. Mishan now expects that the medical equipment provider will post earnings of $4.13 per share for the year, up from their previous forecast of $4.05. KeyCorp has a “Buy” rating and a $103.00 price target on the stock. KeyCorp also issued estimates for Steris’ Q4 2018 earnings at $1.22 EPS, FY2019 earnings at $4.69 EPS and FY2020 earnings at $5.17 EPS.

A number of other equities research analysts have also weighed in on STE. Northcoast Research set a $102.00 price objective on Steris and gave the company a “buy” rating in a research note on Thursday, February 8th. Zacks Investment Research upgraded Steris from a “hold” rating to a “buy” rating and set a $103.00 price objective for the company in a research note on Tuesday, January 23rd. Raymond James Financial lifted their target price on Steris from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Finally, TD Securities lifted their target price on Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research report on Thursday, November 9th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $84.80.

Shares of Steris (NYSE:STE) traded down $1.53 during midday trading on Monday, reaching $84.33. The company’s stock had a trading volume of 234,537 shares, compared to its average volume of 381,952. Steris has a 12-month low of $67.55 and a 12-month high of $93.71. The company has a current ratio of 2.82, a quick ratio of 2.22 and a debt-to-equity ratio of 0.46. The firm has a market cap of $7,260.45, a price-to-earnings ratio of 21.29 and a beta of 1.22.

Steris (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.05. Steris had a return on equity of 11.57% and a net margin of 9.42%. The firm had revenue of $661.90 million during the quarter, compared to analyst estimates of $663.17 million. During the same quarter last year, the firm earned $0.98 EPS. Steris’s quarterly revenue was up 2.3% on a year-over-year basis.

Several institutional investors and hedge funds have recently modified their holdings of STE. Meeder Asset Management Inc. grew its position in shares of Steris by 1,122.4% in the 4th quarter. Meeder Asset Management Inc. now owns 1,198 shares of the medical equipment provider’s stock worth $104,000 after acquiring an additional 1,100 shares in the last quarter. YorkBridge Wealth Partners LLC acquired a new position in shares of Steris in the 4th quarter worth approximately $113,000. Zions Bancorporation acquired a new position in shares of Steris in the 3rd quarter worth approximately $178,000. Citigroup Inc. acquired a new position in shares of Steris in the 2nd quarter worth approximately $206,000. Finally, ARP Americas LP acquired a new position in shares of Steris in the 4th quarter worth approximately $255,000. Institutional investors own 89.47% of the company’s stock.

In other news, VP Sudhir K. Pahwa sold 2,000 shares of Steris stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $92.09, for a total value of $184,180.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 2.55% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “Steris PLC Expected to Post FY2018 Earnings of $4.13 Per Share (STE)” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Earnings History and Estimates for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with's FREE daily email newsletter.